Marksans Pharma gets EIR from USFDA for New York unit

Marksans Pharma gets EIR from USFDA for New York unit In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company#39;s manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".

No comments:

Post a Comment